Haoyan Wang
9th Floor, No.6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Peripheral PD-1⁺CD8⁺ T-cell TCR Dynamics During Radiation Therapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: August 19, 2025
cfDNA methylation detection as potential liquid biopsy of multiple organ injury in myocarditis patients.
Journal: Clinical epigenetics
Published: January 02, 2025
Exercise Prescription Training in Chronic Obstructive Pulmonary Disease: Benefits and Mechanisms.
Journal: International journal of chronic obstructive pulmonary disease
Published: December 14, 2024
Stability of Neutrophil to Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Relationship with Clinical Outcomes: A Retrospective Cohort Study.
Journal: International journal of chronic obstructive pulmonary disease
Published: August 27, 2024
Efficacy and safety of inhaled ambroxol hydrochloride solution in patients with lower respiratory tract infectious diseases: a randomized, double-blind, placebo-controlled, multicentre clinical trial.
Journal: BMC infectious diseases
Published: August 13, 2024
Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway.
Journal: Journal of inflammation (London, England)
Published: August 22, 2023
MARVELD3 inhibits the epithelial-mesenchymal transition and cell migration by suppressing the Wnt/β-catenin signaling pathway in non-small cell lung cancer cells.
Journal: Thoracic cancer
Published: December 24, 2022
Hotspots and Frontiers of Host Immune Response in Idiopathic Pulmonary Fibrosis: A Bibliometric and Scientific Visual Research from 2000 to 2022.
Journal: Journal of immunology research
Published: November 10, 2022
RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway.
Journal: European journal of pharmacology
Published: December 01, 2020
Last Updated: 09/26/2026